Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Δ3 on estrogenic ligands with different intrinsic activity

Oncogene

Volumn 23, Issue 2, 2004, Pages 403-409

  Reiter, Ronald ^a   Oh, Annabell S ^a   Wellstein, Anton ^a,b   Riegel, Anna Tate ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

AIB1; Coactivator; ER; Estrogen

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; ISOPROTEIN; NUCLEIC ACID BINDING PROTEIN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID RECEPTOR COACTIVATOR 3; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; ENDOMETRIUM CANCER; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL;

ANIMALIA; FALLOPIA;

EID: 0842308305     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207202     Document Type: Article

References (39)

1. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM and Meltzer PS. (1997). Science, 277, 965-968.
2. Aravind L and Ponting CP. (1997). Curr. Biol., 7, 674-677.
3. Augereau P, Miralles F, Cavailles V, Gaudelet C, Parker M and Rochefort H. (1994). Mol. Endocrinol., 8, 693-703.
4. Bautista S, Valles H, Walker SL, Anzick S, Zellinger R, Meltzer P and Theillet C. (1998). Clin. Cancer Res., 4, 2925-2929.
5. Bouras T, Southey MC and Venter DJ. (2001). Cancer Res., 61, 903-907.
6. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y and Evans RM. (1997). Cell, 90, 569-580.
7. Couse JF, Lindzey J, Grandien K, Gustafsson JA and Korach KS. (1997). Endocrinology, 138, 4613-4621.
8. Fan C-M and Crews ST. (1999). Curr Opin. Genet. Dev., 9, 580-587.
9. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL and Cronin WM. (1994). J. Natl. Cancer Inst., 86, 527-537.
10. Glass CK and Rosenfeld MG. (2000). Genes Dev., 14, 121-141.
11. Guan XY, Xu J, Anzick SL, Zhang H, Trent JM and Meltzer PS. (1996). Cancer Res., 56, 3446-3450.
12. Hall JM and McDonnell DP. (1999). Endocrinology, 140, 5566-5578.
13. Jordan VC. (2002). Cancer Cell, 1, 215-217.
14. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S and Gustafsson JA. (1997). Endocrinology, 138, 863-870.
15. Kurebayashi J, Otsuki T, Kunisue H, Tanaka K, Yamamoto S and Sonoo H. (2000). Clin Cancer Res., 6, 512-518.
16. Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R and Elgavish A. (2002). J. Nutr., 132, 552S-558S.
17. Leo C and Chen JD. (2000). Gene, 245, 1-11.
18. Li H, Gomes PJ and Chen JD. (1997). Proc. Natl. Acad. Sci. USA, 94, 8479-8484.
19. List HJ, Lauritsen KJ, Reiter R, Powers C, Wellstein A and Riegel AT. (2001a). J. Biol. Chem., 276, 23763-23768.
20. List HJ, Reiter R, Singh B, Wellstein A and Riegel AT. (2001b). Breast Cancer Res. Treat., 68, 21-28.
21. Liu H, Park W-J, Bentrem DJ, McKian KP, De Los Reyes A, Loweth JA, Schafer JM, Zapf JW and Jordan VC. 2002. J. Biol. Chem., 277, 9189-9198.
22. McKenna NJ, Lanz RB and O'Malley BW. (1999). Endocr. Rev., 20, 321-344.
23. Murphy LC, Simon SL, Parkes A, Leygue E, Dotzlaw H, Snell L, Troup S, Adeyinka A and Watson PH. (2000). Cancer Res., 60, 6266-6271.
24. Nilsson S and Gustafsson JA. (2002). Crit. Rev. Biochem. Mol. Biol., 37, 1-28.
25. Onate SA, Tsai SY, Tsai M-J and O'Malley BW. (1995). Science, 270, 1354-1357.
26. Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SA, Wong J, Allred DC, Clark GM and Schiff R. (2003). J. Natl. Cancer Inst., 95, 353-361.
27. Paige LA, Christensen DJ, Gron H, Norris JD, Gottlin EB, Padilla KM, Chang CY, Ballas LM, Hamilton PT, McDonnell DP and Fowlkes DM. (1999). Proc. Natl. Acad. Sci. USA, 96, 3999-4004.
28. Reiter R, Wellstein A and Riegel AT. (2001). J. Biol. Chem., 276, 39736-39741.
29. Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P and Rochefort H. (2001). Cancer Res., 61, 2537-2541.
30. Shang Y and Brown M. (2002). Science, 295, 2465-2468.
31. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA and Greene GL. (1998). Cell, 95, 927-937.
32. Suen CS, Berrodin TJ, Mastroeni R, Cheskis BJ, Lyttle CR and Frail DE. (1998). J. Biol. Chem., 273, 27645-27653.
33. Szapary D, Huang Y and Simons Jr SS. (1999). Mol. Endocrinol., 13, 2108-2121.
34. Takeshita A, Cardona GR, Koibuchi N, Suen CS and Chin WW. (1997). J. Biol. Chem., 272, 27629-27634.
35. Tikkanen MK, Carter DJ, Harris AM, Le HM, Azorsa DO, Meltzer PS and Murdoch FE. (2000). Proc. Natl. Acad. Sci. USA, 97, 12536-12540.
36. Voegel JJ, Heine MJS, Zechel C, Chambon P and Gronmeyer H. (1996). EMBO J., 15, 3667-3675.
37. Watanabe T, Inoue S, Hiroi H, Orimo A, Kawashima H and Muramatsu M. (1998). Mol. Cell. Biol., 18, 442-449.
38. Xu J, Liao L, Ning G, Yoshida-Komiya H, Deng C and O'Malley BW. (2000). Proc. Natl. Acad. Sci. USA, 97, 6379-6384.
39. Zava DT and Duwe G. (1997). Nutr. Cancer, 27, 31-40.